Atta Behfar

Rion Health
CEO
Atta Behfar, M.D., Ph.D., is a transplant cardiologist and Associate Professor of Medicine at Mayo Clinic. He is the Braswell Deputy Director for Translation and Director of the Van Cleve Cardiac Regenerative Medicine Program in the Mayo Clinic Center for Regenerative Medicine. Dr. Behfar and his colleagues aim to develop technologies that will regenerate heart tissue, significantly improving the quality of life in heart disease patients. He also leads biomanufacturing activities for new products such focused on immune, cellular and cell-free exosome therapies that have new potential to be stored on hospital shelves throughout the world. He earned his Medical Doctorate at the Mayo Clinic College of Medicine, a Doctorate in Molecular Pharmacology and Experimental Therapeutics at the Mayo Graduate School and a Bachelor of Science degree in biochemistry from Marquette University. He is a co-founder of Rion, LLC a biotechnology company focused on bringing regenerative exosome technology as an “off-the-shelf” therapeutic to patients. <br/>